Human papillomavirus E5 oncoprotein: function and potential target for antiviral therapeutics

ABSTRACT  Mucosal human papillomaviruses express a small, hydrophobic, protein called E5, which plays an important role in the HPV life cycle by delaying normal epithelial cell differentiation while maintaining cell cycle progression. In addition, E5 exhibits transforming abilities in a number of cell culture systems and transgenic mouse models. Lacking any described enzymatic activity, E5 is thought to function by binding to host proteins and modulating their activities. In particular, members of the growth factor receptor family are known targets for subversion. This review article summarizes our latest understanding of this enigmatic oncoprotein, including its role in the HPV life cycle, interactions with host proteins and contribution toward tumorigenesis.

[1]  D. DiMaio,et al.  The E5 proteins. , 2013, Virology.

[2]  Kristina M. Giorda,et al.  Viroporins customize host cells for efficient viral propagation. , 2013, DNA and cell biology.

[3]  F. Belleudi,et al.  HPV16 E5 and KGFR/FGFR2b interplay in differentiating epithelial cells , 2013, Oncotarget.

[4]  C. Fishwick,et al.  High-Risk Human Papillomavirus E5 Oncoprotein Displays Channel-Forming Activity Sensitive to Small-Molecule Inhibitors , 2012, Journal of Virology.

[5]  F. Belleudi,et al.  HPV16 E5 affects the KGFR/FGFR2b-mediated epithelial growth through alteration of the receptor expression, signaling and endocytic traffic , 2011, Oncogene.

[6]  L. Nasir,et al.  Papillomavirus E5: the smallest oncoprotein with many functions , 2011, Molecular Cancer.

[7]  R. Schlegel,et al.  The Human Papillomavirus Type 16 E5 Oncoprotein Translocates Calpactin I to the Perinuclear Region , 2011, Journal of Virology.

[8]  D. Greco,et al.  Human Papillomavirus 16 E5 Modulates the Expression of Host MicroRNAs , 2011, PloS one.

[9]  E. Jordanova,et al.  Molecular mechanisms of epidermal growth factor receptor overexpression in patients with cervical cancer , 2011, Modern Pathology.

[10]  Marc S. Cortese,et al.  HPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cells. , 2010, Virology.

[11]  R. Schlegel,et al.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes. , 2010, Biochemical and biophysical research communications.

[12]  S. Kōzuma,et al.  CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV , 2010, Journal of Virology.

[13]  R. Schlegel,et al.  The Human Papillomavirus Type 16 E5 Oncoprotein Inhibits Epidermal Growth Factor Trafficking Independently of Endosome Acidification , 2010, Journal of Virology.

[14]  E. Lam,et al.  The human papillomavirus type 16 E5 oncoprotein synergizes with EGF-receptor signaling to enhance cell cycle progression and the down-regulation of p27(Kip1). , 2010, Virology.

[15]  M. Cortese,et al.  All 4 di‐leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization , 2010, International journal of cancer.

[16]  H. Pitot,et al.  A role for HPV16 E5 in cervical carcinogenesis. , 2010, Cancer research.

[17]  Y. Song,et al.  Human papillomavirus type 16 E5 protein inhibits hydrogen-peroxide-induced apoptosis by stimulating ubiquitin-proteasome-mediated degradation of Bax in human cervical cancer cells. , 2010, Carcinogenesis.

[18]  R. Schlegel,et al.  The Canine Papillomavirus E5 Protein Signals from the Endoplasmic Reticulum , 2009, Journal of Virology.

[19]  Y. Song,et al.  Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. , 2009, Carcinogenesis.

[20]  Y. Song,et al.  Human papillomavirus E5 protein induces expression of the EP4 subtype of prostaglandin E2 receptor in cyclic AMP response element-dependent pathways in cervical cancer cells. , 2009, Carcinogenesis.

[21]  L. Laimins,et al.  Bap31 Is a Novel Target of the Human Papillomavirus E5 Protein , 2008, Journal of Virology.

[22]  J. Hanover,et al.  Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein. , 2008, Biochemical and biophysical research communications.

[23]  D. Greco,et al.  Genes involved in cell adhesion, cell motility and mitogenic signaling are altered due to HPV 16 E5 protein expression , 2008, Oncogene.

[24]  R. Schlegel,et al.  HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells , 2008, Oncogene.

[25]  J. Chou,et al.  Structure and mechanism of the M2 proton channel of influenza A virus , 2008, Nature.

[26]  F. Momburg,et al.  The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cells , 2007, Virology Journal.

[27]  H. Pitot,et al.  Human papillomavirus 16 E5 oncogene contributes to two stages of skin carcinogenesis. , 2007, Cancer research.

[28]  S. Werner,et al.  The role of fibroblast growth factor receptor 2b in skin homeostasis and cancer development , 2007, The EMBO journal.

[29]  R. Knight,et al.  TAp63 and ΔNp63 in Cancer and Epidermal Development , 2007 .

[30]  Y. Tsao,et al.  ErbB4 (JM-b/CYT-1)-induced expression and phosphorylation of c-Jun is abrogated by human papillomavirus type 16 E5 protein , 2007, Oncogene.

[31]  M. Campo,et al.  Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. , 2006, Virus research.

[32]  M. Campo,et al.  The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus , 2006, Oncogene.

[33]  A. Srirangam,et al.  HPV16 E5 protein disrupts the c-Cbl–EGFR interaction and EGFR ubiquitination in human foreskin keratinocytes , 2005, Oncogene.

[34]  M. Campo,et al.  E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I , 2005, International journal of cancer.

[35]  V. Piguet.  Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation. , 2005, Current topics in microbiology and immunology.

[36]  Kazuro Furukawa,et al.  Over-expression of GM1 enhances cell proliferation with epidermal growth factor without affecting the receptor localization in the microdomain in PC12 cells. , 2005, International journal of oncology.

[37]  A. Alonso,et al.  The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes , 2005, Archives of Virology.

[38]  A. Alonso,et al.  Mucosal Human Papillomaviruses Encode Four Different E5 Proteins Whose Chemistry and Phylogeny Correlate with Malignant or Benign Growth , 2004, Journal of Virology.

[39]  M. Campo,et al.  Cyclin A expression and growth in suspension can be uncoupled from p27 deregulation and extracellular signal-regulated kinase activity in cells transformed by bovine papillomavirus type 4 E5. , 2004, The Journal of general virology.

[40]  P. Auvinen,et al.  Human papillomavirus type 16 E5 protein colocalizes with the antiapoptotic Bcl-2 protein , 2004, Archives of Virology.

[41]  G. Komposch,et al.  The HPV-16 E5 Protein Inhibits TRAIL- and FasL-Mediated Apoptosis in Human Keratinocyte Raft Cultures , 2004, Intervirology.

[42]  Y. Tsao,et al.  Cytotoxic-T-Lymphocyte Human Papillomavirus Type 16 E5 Peptide with CpG-Oligodeoxynucleotide Can Eliminate Tumor Growth in C57BL/6 Mice , 2004, Journal of Virology.

[43]  A. Alonso,et al.  The Human Papillomavirus Type 16 E5 Protein Modulates ERK1/2 and p38 MAP Kinase Activation by an EGFR-Independent Process in Stressed Human Keratinocytes , 2000, Virus Genes.

[44]  A. Alonso,et al.  The human papillomavirus HPV2a E5 protein localizes to the Golgi apparatus and modulates signal transduction. , 2003, Virology.

[45]  A. Wildeman,et al.  Oligomerization of the E5 protein of human papillomavirus type 16 occurs through multiple hydrophobic regions. , 2003, Virology.

[46]  E. Wang,et al.  The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-gamma. , 2003, Virology.

[47]  D. Klumpp,et al.  Human Papillomavirus Type 31 E5 Protein Supports Cell Cycle Progression and Activates Late Viral Functions upon Epithelial Differentiation , 2003, Journal of Virology.

[48]  K. Münger,et al.  Quantitative Role of the Human Papillomavirus Type 16 E5 Gene during the Productive Stage of the Viral Life Cycle , 2003, Journal of Virology.

[49]  A. Alonso,et al.  The Human Papillomavirus Type 16 E5 Protein Impairs TRAIL- and FasL-Mediated Apoptosis in HaCaT Cells by Different Mechanisms , 2002, Journal of Virology.

[50]  M. Campo,et al.  The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface , 2002, Oncogene.

[51]  M. Campo,et al.  Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins , 2002, Oncogene.

[52]  D. Spandau,et al.  E5 Protein of Human Papillomavirus Type 16 Protects Human Foreskin Keratinocytes from UV B-Irradiation-Induced Apoptosis , 2002, Journal of Virology.

[53]  U. Ritz,et al.  Deficient expression of components of the MHC class I antigen processing machinery in human cervical carcinoma. , 2001, International journal of oncology.

[54]  Y. Tsao,et al.  The Expression of HPV-16 E5 Protein in Squamous Neoplastic Changes in the Uterine Cervix , 2001, Journal of Biomedical Science.

[55]  B. Deurs,et al.  The HPV16 E5 oncogene inhibits endocytic trafficking , 2000, Oncogene.

[56]  Jin-Hyuk Choi,et al.  Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[57]  R. Young,et al.  Cervical Epidermal Growth Factor‐Receptor (EGF‐R) and Serum Insulin‐Like Growth Factor II (IGF‐II) Levels are Potential Markers for Cervical Cancer 1 , 2000, American journal of reproductive immunology.

[58]  J. Hsieh,et al.  Induction of CD8 T Cells by Vaccination with Recombinant Adenovirus Expressing Human Papillomavirus Type 16 E5 Gene Reduces Tumor Growth , 2000, Journal of Virology.

[59]  S. Stacey,et al.  Leaky Scanning Is the Predominant Mechanism for Translation of Human Papillomavirus Type 16 E7 Oncoprotein from E6/E7 Bicistronic mRNA , 2000, Journal of Virology.

[60]  A. Alonso,et al.  Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation , 2000, Oncogene.

[61]  E. Flores,et al.  The Human Papillomavirus Type 16 E7 Oncogene Is Required for the Productive Stage of the Viral Life Cycle , 2000, Journal of Virology.

[62]  D. McCance,et al.  A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems. , 2000, Virology.

[63]  H. Cheng,et al.  Modulation of the epidermal growth factor receptor by the human papillomavirus type 16 E5 protein in raft cultures of human keratinocytes. , 2000, European journal of cell biology.

[64]  V. Kinzel,et al.  The human papillomavirus type 16 E5 protein modulates phospholipase C-γ-1 activity and phosphatidyl inositol turnover in mouse fibroblasts , 1999, Oncogene.

[65]  E. Flores,et al.  Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line. , 1999, Virology.

[66]  E. Auvinen,et al.  The human papillomavirus type 16 E5-protein modulates ligand-dependent activation of the EGF receptor family in the human epithelial cell line HaCaT. , 1998, Experimental cell research.

[67]  M. Ozbun,et al.  Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA , 1997, Journal of virology.

[68]  E. Auvinen,et al.  Enhancement of EGF- and PMA-mediated MAP kinase activation in cells expressing the human papillomavirus type 16 E5 protein , 1997, Oncogene.

[69]  W. Wang,et al.  E5 proteins of human papillomavirus types 11 and 16 transactivate the c-fos promoter through the NF1 binding element , 1996, Journal of virology.

[70]  Y. Tsao,et al.  Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes , 1996, Journal of virology.

[71]  G. Matlashewski,et al.  Effect of human papillomavirus type 16 oncogenes on MAP kinase activity , 1995, Journal of virology.

[72]  O. Dirsch,et al.  Modulation of Keratinocyte Growth Factor and Its Receptor in Reepithelializing Human Skin , 2003 .

[73]  D. DiMaio,et al.  The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells. , 1995, Virology.

[74]  D. McCance,et al.  The E5 oncoprotein of human papillomavirus type 16 inhibits the acidification of endosomes in human keratinocytes , 1995, Journal of virology.

[75]  L. Banks,et al.  The human papillomavirus (HPV)-6 and HPV-16 E5 proteins co-operate with HPV-16 E7 in the transformation of primary rodent cells. , 1995, The Journal of general virology.

[76]  L. Banks,et al.  The human papillomavirus type 16 E5 gene cooperates with the E7 gene to stimulate proliferation of primary cells and increases viral gene expression. , 1994, Virology.

[77]  R. Schlegel,et al.  The human papillomavirus type 6 and 16 E5 proteins are membrane-associated proteins which associate with the 16-kilodalton pore-forming protein , 1993, Journal of virology.

[78]  D. McCance,et al.  The E5 oncoprotein of human papillomavirus type 16 transforms fibroblasts and effects the downregulation of the epidermal growth factor receptor in keratinocytes , 1993, Journal of virology.

[79]  C. Meijer,et al.  Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions. , 1993, British Journal of Cancer.

[80]  C. Meyers,et al.  Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. , 1992, Science.

[81]  T. Fleming,et al.  Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[82]  L. Banks,et al.  The E5 gene from human papillomavirus type 16 is an oncogene which enhances growth factor-mediated signal transduction to the nucleus. , 1992, Oncogene.

[83]  D. Pim,et al.  Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor. , 1992, Oncogene.

[84]  D. DiMaio,et al.  Tumorigenic transformation of murine keratinocytes by the E5 genes of bovine papillomavirus type 1 and human papillomavirus type 16 , 1991, Journal of virology.

[85]  P. Mounts,et al.  Detection by antibody probes of human papillomavirus type 6 E5 proteins in respiratory papillomata , 1989, Journal of medical virology.

[86]  Wolfgang Mayer,et al.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells , 1985, Nature.